High-Dose Intravenous ?-Immunoglobulin Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura
- 1 December 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 147 (12) , 2165-2167
- https://doi.org/10.1001/archinte.1987.00370120101017
Abstract
† Thrombotic thrombocytopenic purpura has been treated with plasmapheresis, exchange transfusion, splenectomy, antiplatelet compounds, glucocorticoids, and vincristine sulfate infusion. We describe a patient with thrombotic thrombocytopenic purpura who has failed on treatment with plasmapheresis, antiplatelet compounds, glucocorticoids, and vincristine, was successfully treated with high-dose γ-immunoglobulin infusion, and has been maintained in prolonged remission without further immunoglobulin infusion for more than 14 months at the time of this report. (Arch Intern Med 1987;147:2165-2167)This publication has 6 references indexed in Scilit:
- Treatment of Thrombotic Thrombocytopenic Purpura with Combined Exchange Plasmapheresis and Anti-platelet AgentsSeminars in Thrombosis and Hemostasis, 1981
- Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraSeminars in Thrombosis and Hemostasis, 1981
- Treatment of Thrombotic Thrombocytopenic Purpura With Plasma Infusions and CyclophosphamideSouthern Medical Journal, 1979
- Recent Therapeutic Advances in Thrombotic Thrombocytopenic PurpuraSeminars in Thrombosis and Hemostasis, 1979
- Treatment of Thrombotic Thrombocytopenic Purpura with PlasmaNew England Journal of Medicine, 1977
- Antiplatelet Treatment of Thrombotic Thrombocytopenic PurpuraAnnals of Internal Medicine, 1977